Guangzhou Hehong Biotechnology Co., Ltd. was established in 2017 and is located in the Guangdong-Hong Kong-Macao Greater Bay Area. It is a professional company focusing on the research, development, production and sales of assisted reproductive and gynecological related medical devices. It is committed to the research and development and production of high-quality IVF products, improving the localization rate of China's assisted reproductive and gynecological products, promoting the application of technology in the field of assisted reproduction, and bringing hope to more infertile families.
Create the "Minvitro" Chinese brand, strive to improve the localization rate of VF products, and break the dependence on foreign technology. The company's current assisted reproductive consumables include vitrified freezing rods, oocyte collectors, embryo transfer catheters, artificial insemination catheters, micromanipulation tubes, freezing brackets, etc., and continue to independently develop a series of VF products. At present, the products have obtained multiple medical device registration certificates and have been exported to Europe, the Middle East, Africa, Southeast Asia and South America, and have been recognized by clinical and laboratory experts.
The company has a total area of 2,000 square meters, of which the 100,000-level workshop is about 500 square meters, and is equipped with complete cell, microbial and physical and chemical laboratories, which can conduct comprehensive testing of products. It is equipped with various production and processing equipment such as injection molding, extrusion, cutting-edge processing, ultrasound, and blister packaging. Large-scale testing instruments include gas chromatographs and dust particle counters. It is equipped with multiple clean benches to ensure that product quality meets international standard CO2 incubators/dust particle counters, and is equipped with multiple Class 100 clean benches and dozens of professional testing equipment.
